alexion-pharmaceuticals
Alexion Pharmaceuticals was a global biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing life-transforming therapies for rare diseases. Founded in 1992, the company pioneered complement inhibition therapy and developed leading treatments for rare hematological and neurological conditions including Soliris (eculizumab) and Ultomiris (ravulizumab). AstraZeneca acquired Alexion in July 2021 for $39 billion, and the company now operates as Alexion, AstraZeneca Rare Disease. The combined entity maintains research programs in complement biology, hematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. Alexion's GitHub organization (alxndgb) hosts research tools including genomic data analysis platforms, precision medicine knowledge graphs, and rare disease target discovery systems.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles alexion-pharmaceuticals the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — alexion-pharmaceuticals scores 7.6/100 (minimal), with a separate agent-readiness read of 4/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile alexion-pharmaceuticals
Each block below is one kind of artifact we hold for alexion-pharmaceuticals. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for alexion-pharmaceuticals — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/alexion-pharmaceuticals · machine-readable index on apis.io